Indicia Biotechnology of Oullins (Lyon), France is VTC's assay development partner in Europe. It specializes in nanotech particle technology and develops second generation magnetic assays through to validation and registration.
VTC's exclusive world-wide License Agreement with MagnaBioSciences LLC allows the Corporation to take advantage of progress in magnetic nanotechnology and ensures that it will remain at the cutting edge of this technology.
-
Indicia Biotechnology Inc.
-
Indicia is a French based company which specializes in nano particle technology. Indicia is an expert in the development of second generation magnetic VACCI-TEST™ products. Indicia and VTC have been strategically working together since 2004 in the development of first generation tests and ELISA laboratory diagnostic kits. Currently there are three first generation tests, Tetanus and Leptospirosis (humans) & Brucella (swine) that either have or are expected to receive CE certification in 2008.
Indicia has been certified for compliance with both GLP and ISO 9001:2000 requirements.
For more information please visit: www.indicia.fr
- MagnaBioSciences LLC
-
On November 30, 2007 VTC completed a Licensing and Development Agreement with MBS of San Diego, California that provides VTC with access to MBS' patented magnetic technology ("MICT") for rapid, quantitative food safety testing... VTC has the exclusive world-wide license to use the technology for testing throughout the food safety production chain. MBS is a subsidiary of Quantum Design Inc. ("QD"), a world leader in developing and manufacturing magnetic measurement instruments for materials characterization since 1982.
For more information please visit: www.qdusa.com
